Changjiang Runfa Health Industry Co., Ltd. Share Price

Equities

002435

CNE100000QC7

Heavy Electrical Equipment

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
2.73 CNY 0.00% Intraday chart for Changjiang Runfa Health Industry Co., Ltd. +4.60% -34.53%

Financials

Sales 2021 4.37B 603M 48.17B Sales 2022 3.47B 479M 38.24B Capitalization 5.77B 797M 63.62B
Net income 2021 -413M -57M -4.55B Net income 2022 65M 8.97M 716M EV / Sales 2021 1.36 x
Net cash position 2021 563M 77.64M 6.2B Net cash position 2022 658M 90.8M 7.25B EV / Sales 2022 1.47 x
P/E ratio 2021
-15.8 x
P/E ratio 2022
88.6 x
Employees 2,405
Yield 2021 *
-
Yield 2022
-
Free-Float 45.51%
More Fundamentals * Assessed data
Dynamic Chart
Changjiang Runfa Health Industry Co., Ltd. Approves Board Elections CI
Changjiang Runfa Health Unit's Antibacterial Drug Passes Drug Regulator's Consistency Evaluation MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Changjiang Runfa Health Industry Co., Ltd.(XSEC:002435) added to S&P Global BMI Index CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. completed the acquisition of 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Rongtong No. 5 Securities Investment Fund, managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire a 5.99% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. agreed to acquire 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. for approximately CNY310 million. CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Changjiang Runfa Health Boosts Stake in Jianghe Pharmaceutical to 87% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Changjiang Runfa Health Buys 58% of Peer for 39 Million Yuan; Shares Rally 10% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Changjiang Runfa Health's Shareholder and Parties Acting in Concert Plan to Cut Stakes CI
More news
1 week+4.60%
Current month-13.06%
1 month-13.06%
3 months-28.53%
6 months-38.51%
Current year-34.53%
More quotes
1 week
2.62
Extreme 2.62
2.76
1 month
2.55
Extreme 2.55
3.39
Current year
2.38
Extreme 2.38
4.26
1 year
2.38
Extreme 2.38
5.04
3 years
2.38
Extreme 2.38
9.89
5 years
2.38
Extreme 2.38
9.89
10 years
2.38
Extreme 2.38
9.89
More quotes
Managers TitleAgeSince
Director of Finance/CFO 52 22/04/19
President 50 22/04/19
Director/Board Member 46 21/10/07
Members of the board TitleAgeSince
Director/Board Member 60 21/10/07
Chairman 61 21/10/07
Director/Board Member 83 21/10/07
More insiders
Date Price Change Volume
26/04/24 2.73 0.00% 9,152,991
25/04/24 2.73 +1.87% 8,140,891
24/04/24 2.68 -0.37% 7,378,455
23/04/24 2.69 +2.28% 10,257,090
22/04/24 2.63 +0.77% 9,518,352

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Company’s products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 002435 Stock